(Press-News.org) Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with an occurrence rate in France similar to multiple sclerosis (two to three new cases per year for every 100,000 residents). It has a specific affect on neurons responsible for motor control, in particular motor neurones and central motor neurones. The former, located in the spinal cord, are directly linked to muscles and are used for muscle contraction and stretching. The latter, located in the brain, receive movement orders. As the disease develops, the neurons degenerate and the muscles are no longer stimulated and stop working. Movements, walking and speech become increasingly difficult and patients tend to pass away an average of two to five years after diagnosis, generally due to respiratory failure.
Paralysis is accompanied by other symptoms, which can be highly disabling on a daily basis. Spasms (or spasticity) are an exaggerated muscular response to a stimulus; they produce long and involuntary muscle contractions, coupled with pain. Spasticity is frequently observed in ALS. Until now, it was attributed to the loss of central motor neurons.
In this study, Inserm researchers have shown that these spasms are, in fact, linked to the degeneration of another type of serotonin-producing neurons located on the brain.
They have observed - both in patients with ALS and in a transgenic mouse model - that serotonergic neurons waste away as the disease develops and that serotonin levels in the spinal cord sharply decreased before the motor-related symptoms appeared.
Furthermore, some molecules active against serotonin receptors eliminate spasms in transgenic mice suffering from ALS. This research demonstrates that neuron degeneration in ALS is not limited to the motor system in its strictest sense. For Luc Dupuis "molecules acting on serotonin receptors 5-HT2B and C could be antispastic for ALS patients over the long-term".
###This work is protected by a patent filed by Inserm Transfert.
Sources
Degeneration of serotonin neurons in amyotrophic lateral sclerosis: a link to spasticity
Christel DENTEL, MD1,2,3, Lavinia PALAMIUC, MaSc1,2, Alexandre HENRIQUES, PhD1,2 Béatrice LANNES, MD, PhD2,4, Odile SPREUX-VAROQUAUX, PhD5,6,7, Lise GUTKNECHT, PhD8,9, Frédérique RENE, PhD1,2, Andoni ECHANIZ-LAGUNA, MD, PhD1,2,3, Jose-Luis GONZALEZ DE AGUILAR, PhD1,2, Klaus Peter LESCH, MD8,10, Vincent MEININGER, MD, PhD11,12 Jean-Philippe LOEFFLER, PhD1,2 & Luc DUPUIS, PhD1,2,12,13
A new development in the relief of spasms related to amyotrophic lateral sclerosis
2012-11-06
ELSE PRESS RELEASES FROM THIS DATE:
Pressure switch inside the head
2012-11-06
To this day it remains a mystery why the cerebral pressure in certain people suddenly increases. The consequences, however, are better understood: The blood circulation is disrupted and after a while parts of the brain may die off, similar to what occurs in a stroke. This is how dementia takes its insidious path. Experts estimate that up to ten percent of all cases of dementia in Europe can be attributed to rising blood pressure in the brain. Still, making the diagnosis is tough. People with a heightened susceptibility to a rise in intracranial pressure must be treated ...
Quality products from rubber residues
2012-11-06
Each year throughout the world, up to 22 million tons of rubber are processed and a large portion of it goes into the production of vehicle tires. Once the products reach the end of their useful life, they typically land in the incinerator. In the best case, the waste rubber is recycled into secondary products. Ground to powder, the rubber residues can be found, for example, in the floor coverings used at sports arenas and playgrounds, and in doormats. But until now, the appropriate techniques for producing high-quality materials from these recyclables did not exist. Researchers ...
Long shifts lead to nurse burnout and dissatisfied patients
2012-11-06
Extended work shifts of twelve hours or longer are common and popular among hospital staff nurses, but a new study reports that nurses working longer shifts were more likely to experience burnout, job dissatisfaction, and patients were more dissatisfied with their care.
In the first study to examine the relationship between nurse shift length and patients' assessment of care, researchers from the University of Pennsylvania School of Nursing report that nurses working shifts of ten hours or longer were up to two and a half times more likely than nurses working shorter ...
Temple researchers show targeted cancer drug may stunt heart's ability to repair itself
2012-11-06
(Philadelphia, PA) – Scientists for the first time have evidence showing how a widely used type of "targeted" cancer drug can be dangerous to the heart.
Studying mice with the equivalent of a heart attack, researchers found that the drug sorafenib (Nexavar) – which inhibits proteins called tyrosine kinase receptors (RTKs), and is used in kidney and liver cancer treatment – can interfere with heart stem cell activity, affecting the heart's ability to repair itself after injury. The findings suggest that sorafenib and other similar drugs that target these kinds of protein ...
Losing protein helps heart recover, say Temple scientists
2012-11-06
(Philadelphia, PA) – When a person has a heart attack, portions of the heart muscle die in the next several days or even weeks if deprived of oxygen for long enough. The recovering heart slowly remodels itself, even fostering the growth of new blood vessels, in an attempt to regain some of its former function. But all too often, the remodeling is actually harmful, and the damaged heart is on an inevitable downward slide to heart failure.
Now, scientists at the Center for Translational Medicine at Temple University School of Medicine have identified a key target they hope ...
Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
2012-11-06
DUBLIN, November 6, 2012 – Taiho Pharmaceutical Co., Ltd. (HQ: Tokyo, President: Masayuki Kobayashi), the developer of the first orally available fluorouracil (FU) Chemotherapeutic treatment (TS-1/S-1), is presenting early stage data for eight novel oncology compounds, including potential first-in-class therapies. The data being presented during the 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics from November 6 – 9, 2012 in Dublin, Ireland underscore Taiho's steadfast commitment to improving cornerstone anti-metabolic cancer agents and developing ...
Rebuilding a whole heart for children born with only half of 1
2012-11-06
Boston, Mass.—Using a combination of surgical procedures developed over the last 11 years, surgeons at Boston Children's Hospital have established a new approach for rebuilding the heart in children born with a severe heart defect called hypoplastic left heart syndrome (HLHS). This "staged left ventricle recruitment" (SLVR) strategy uses the existing standard single-ventricle treatment for HLHS and additional procedures to spur the body's capacity for healing and growth and encourage the small left ventricle in these children to grow and function.
Members of Boston Children's ...
How bacteria talk to each other and our cells
2012-11-06
Bacteria can talk to each other via molecules they themselves produce. The phenomenon is called quorum sensing, and is important when an infection propagates. Now, researchers at Linköping University in Sweden are showing how bacteria control processes in human cells the same way.
The results are being published in the journal PLOS Pathogens with Elena Vikström, researcher in Medical Microbiology, as the main author.
When an infection is signaled, more and more bacteria gather at the site of the attack – a wound, for example. When there are enough of them, they start ...
Combating a crisis: Global burden of preterm birth can be reduced if critical actions are taken
2012-11-06
New surveys of researchers and funders reveal a lack of consensus regarding researching and developing interventions to prevent prematurity and stillbirth, according to an article published in the American Journal of Obstetrics and Gynecology ahead of World Prematurity Day on November 17.
Authored by Michael G. Gravett, MD, scientific director of the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS), an initiative of Seattle Children's, and Craig E. Rubens, MD, PhD, executive director of GAPPS, the article outlines significant opportunities to enhance research ...
New bacteria to fight against intestinal inflammation
2012-11-06
This protection is provided by a human protein, Elafin, which is artificially introduced into dairy produce bacteria (Lactococcus lactis and Lactobacillus casei). In time, this discovery could be useful for individuals suffering from chronic inflammatory diseases such as Crohn's disease or ulcerative colitis.
The results of this research were published in the Science Translational Medicine review on 31 October 2012.
In France, nearly 200,000 individuals suffer from chronic inflammatory bowel disease, known as IBD, (specifically Crohn's disease and ulcerative colitis). ...